Cite
HARVARD Citation
Süssmuth, S. et al. (n.d.). Q02 A randomised, double-blind, placebo-controlled phase IB pharmacodynamic study with selisistat (SEN0014196) in HD patients. Journal of neurology, neurosurgery and psychiatry. p. A55. [Online].